Beth Andrews

1.3k total citations
13 papers, 705 citations indexed

About

Beth Andrews is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Beth Andrews has authored 13 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 3 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in Beth Andrews's work include Cancer therapeutics and mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Antifungal resistance and susceptibility (2 papers). Beth Andrews is often cited by papers focused on Cancer therapeutics and mechanisms (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Antifungal resistance and susceptibility (2 papers). Beth Andrews collaborates with scholars based in United States, United Kingdom and Brazil. Beth Andrews's co-authors include P. Doig, T J Trust, Robert E. W. Hancock, James E. Bina, Richard A. Alm, Maurice M. Moloney, Vic Knauf, Jean C. Kridl, Martha L. Crouch and Adam B. Shapiro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Beth Andrews

13 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Andrews United States	10	396	232	186	120	88	13	705
Aleksandra W. Debowski Australia	14	554 1.4×	193 0.8×	238 1.3×	35 0.3×	433 4.9×	35	875
A. Bekierkunst Israel	17	282 0.7×	111 0.5×	297 1.6×	60 0.5×	81 0.9×	54	1000
James A. D. Good Sweden	13	188 0.5×	102 0.4×	73 0.4×	19 0.2×	122 1.4×	17	571
Gustavo Stadthagen France	10	375 0.9×	60 0.3×	107 0.6×	33 0.3×	65 0.7×	11	762
Shiva K. Angala United States	16	385 1.0×	55 0.2×	32 0.2×	32 0.3×	180 2.0×	31	740
Ryan H. Senaratne United States	14	418 1.1×	92 0.4×	68 0.4×	38 0.3×	57 0.6×	15	842
Kaija H. Valkonen Finland	13	193 0.5×	187 0.8×	153 0.8×	30 0.3×	22 0.3×	27	650
Maju Joe Canada	17	464 1.2×	42 0.2×	153 0.8×	48 0.4×	408 4.6×	27	914
Victoria Jones United States	16	501 1.3×	64 0.3×	47 0.3×	24 0.2×	221 2.5×	19	1.0k
Frank Lindh Sweden	16	288 0.7×	39 0.2×	63 0.3×	134 1.1×	199 2.3×	26	643

Countries citing papers authored by Beth Andrews

Since Specialization

Citations

This map shows the geographic impact of Beth Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Andrews more than expected).

Fields of papers citing papers by Beth Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Andrews. The network helps show where Beth Andrews may publish in the future.

Co-authorship network of co-authors of Beth Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Andrews. A scholar is included among the top collaborators of Beth Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Andrews. Beth Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kern, Günther, Tiffany Palmer, David E. Ehmann, et al.. (2015). Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914. Journal of Biological Chemistry. 290(34). 20984–20994. 39 indexed citations

Uria-Nickelsen, Maria, Georg Neckermann, Beth Andrews, et al.. (2013). Novel topoisomerase inhibitors: microbiological characterisation and in vivo efficacy of pyrimidines. International Journal of Antimicrobial Agents. 41(4). 363–371. 24 indexed citations

Hill, Pamela, Robert Albert, Beth Andrews, et al.. (2013). Selective Inhibitors of Bacterial t-RNA-(N¹G37) Methyltransferase (TrmD) That Demonstrate Novel Ordering of the Lid Domain. Journal of Medicinal Chemistry. 56(18). 7278–7288. 43 indexed citations

Shapiro, Adam B. & Beth Andrews. (2012). Allosteric inhibition of the DNA-dependent ATPase activity of Escherichia coli DNA gyrase by a representative of a novel class of inhibitors. Biochemical Pharmacology. 84(7). 900–904. 13 indexed citations

Stokes, S., Robert Albert, Ed T. Buurman, et al.. (2012). Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamides. Bioorganic & Medicinal Chemistry Letters. 22(23). 7019–7023. 77 indexed citations

Shapiro, Adam B., Philip L. Ross, Ning Gao, et al.. (2012). A High-Throughput–Compatible Fluorescence Anisotropy-Based Assay for Competitive Inhibitors of Escherichia coli UDP-N-Acetylglucosamine Acyltransferase (LpxA). SLAS DISCOVERY. 18(3). 341–347. 8 indexed citations

Buurman, Ed T., Beth Andrews, Ning Gao, et al.. (2011). In Vitro Validation of Acetyltransferase Activity of GlmU as an Antibacterial Target in Haemophilus influenzae. Journal of Biological Chemistry. 286(47). 40734–40742. 39 indexed citations

Buurman, Ed T., et al.. (2005). Utilization of Target-Specific, Hypersensitive Strains of Saccharomyces cerevisiae To Determine the Mode of Action of Antifungal Compounds. Antimicrobial Agents and Chemotherapy. 49(6). 2558–2560. 5 indexed citations

Alm, Richard A., James E. Bina, Beth Andrews, et al.. (2000). Comparative Genomics ofHelicobacter pylori: Analysis of the Outer Membrane Protein Families. Infection and Immunity. 68(7). 4155–4168. 250 indexed citations

10.

Scesney, Susanne M., Savvas C. Makrides, Michael Gosselin, et al.. (1996). A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway. European Journal of Immunology. 26(8). 1729–1735. 28 indexed citations

11.

Andrews, Beth, Hedy Adari, Gerhard Hannig, et al.. (1996). A tightly regulated high level expression vector that utilizes a thermosensitive lac repressor: production of the human T cell receptor Vβ5.3 in Escherichia coli. Gene. 182(1-2). 101–109. 20 indexed citations

12.

Adari, Hedy, Beth Andrews, Pamella J. Ford, et al.. (1995). Expression of the Human T-Cell Receptor Vβ5.3 in Escherichia coli by Thermal Induction of the trc Promoter: Nucleotide Sequence of the lacIts Gene. DNA and Cell Biology. 14(11). 945–950. 7 indexed citations

13.

Andrews, Beth, et al.. (1988). Transformation of Brassica napus L. using Agrobacterium tumefaciens: developmentally regulated expression of a reintroduced napin gene. Theoretical and Applied Genetics. 75(5). 685–694. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact